AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (September 5, 2003). doi:10.1152/ajplung.00420.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/L1088    most recent
00420.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishizaka, A.
Right arrow Articles by Hashimoto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishizaka, A.
Right arrow Articles by Hashimoto, S.
Submitted on December 9, 2002
Accepted on August 26, 2003

Elevation of KL-6, A Lung Epithelial Cell Marker, in Plasma and Epithelial Lining Fluid in the Acute Respiratory Distress Syndrome

Akitoshi Ishizaka1*, Tomoyuki Matsuda2, Kurt H. Albertine3, Hidefumi Koh1, Sadatomo Tasaka1, Naoki Hasegawa1, Nobuoki Kohno4, Toru Kotani5, Hiroshi Morisakai5, Junzo Takeda5, Morio Nakamura1, Xiaohui Fang6, Thomas R. Martin7, Michael A. Matthay6, and Satoru Hashimoto2

1 Department of Medicine, Keio University, School of Medicine, Tokyo, Tokyo, Japan
2 Department of Anesthesiology6, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
3 Department of Pediatrics and Medicine, University of Utah, School of Medicine, Salt Lake City, UT, USA
4 Department of Molecular and Internal Medicine, Hiroshima University, Graduate School of Biomedical Science, Hiroshima, Hiroshima, Japan
5 Department of Anesthesiology, Keio University, School of Medicine, Tokyo, Tokyo, Japan
6 Department of Medicine and Anesthesia, University of California at San Francisco, Cardiovascular Research Institute, San Francisco, CA, USA
7 Department of Medicine, VA/Puget Sound Medical Center, Primary and Specialty Medicine Service Line, Seattle, WA, USA

* To whom correspondence should be addressed. E-mail: ishiz{at}attglobal.net.

KL-6 is a pulmonary epithelial mucin more prominently expressed on the surface membrane of alveolar type II cells when these cells are proliferating, stimulated and/or injured. We hypothesized that high levels of KL-6 in epithelial lining fluid and plasma would reflect the severity of lung injury in patients with acute lung injury (ALI). Epithelial lining fluid was obtained at onset (day 0) and day 1 of ARDS/ALI by bronchoscopic microsampling procedure in 35 patients. On day 0, KL-6 and albumin concentrations in epithelial lining fluid were significantly higher than in normal controls (P <0.001), and the concentrations of KL-6 in epithelial lining fluid (P <0.002) and in plasma (P <0.0001) were higher in non-survivors than in survivors of ALI/ARDS. These observations were corroborated by the immunohistochemical localization of KL-6 protein expression in the lungs of non-survivors with acute lung injury, and KL-6 secretion from cultured human alveolar type II cells stimulated by proinflammatory cytokines. Since injury to distal lung epithelial cells, including alveolar type II cells, is important in the pathogenesis of acute lung injury, the elevation of KL-6 concentrations in plasma and epithelial lining fluid could be valuable indicators for poor prognosis in clinical acute lung injury.




This article has been cited by other articles:


Home page
ThoraxHome page
M L Doan, O Elidemir, M K Dishop, H Zhang, E O Smith, P G Black, R R Deterding, D M Roberts, Q A Al-Salmi, and L L Fan
Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism
Thorax, August 1, 2009; 64(8): 677 - 681.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Kikuchi, J. Kikuchi, Y. Nasuhara, S. Oizumi, A. Ishizaka, and M. Nishimura
Comparison of the Pharmacodynamics of Biapenem in Bronchial Epithelial Lining Fluid in Healthy Volunteers Given Half-Hour and Three-Hour Intravenous Infusions
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 2799 - 2803.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. E. Levitt, M. K. Gould, L. B. Ware, and M. A. Matthay
Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury
J Intensive Care Med, May 1, 2009; 24(3): 151 - 167.
[Abstract] [PDF]


Home page
Eur Respir JHome page
D. J. Lederer, S. Jelic, R. C. Basner, A. Ishizaka, and J. Bhattacharya
Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea
Eur. Respir. J., April 1, 2009; 33(4): 793 - 796.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
S Oue, M Hiroi, S Ogawa, S Hira, M Hasegawa, S Yamaoka, M Yasui, H Tamai, and T Ogihara
Association of gastric fluid microbes at birth with severe bronchopulmonary dysplasia
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2009; 94(1): F17 - F22.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Kipnis, K. Hansen, T. Sawa, K. Moriyama, A. Zurawel, A. Ishizaka, and J. Wiener-Kronish
Proteomic Analysis of Undiluted Lung Epithelial Lining Fluid
Chest, August 1, 2008; 134(2): 338 - 345.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Zambon and J.-L. Vincent
Mortality Rates for Patients With Acute Lung Injury/ARDS Have Decreased Over Time
Chest, May 1, 2008; 133(5): 1120 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Frank, R. Briot, J. W. Lee, A. Ishizaka, T. Uchida, and M. A. Matthay
Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L52 - L59.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Miyazaki, S.-i. Nureki, E. Ono, M. Ando, O. Matsuno, T. Fukami, T. Ueno, and T. Kumamoto
Circulating Thymus- and Activation-Regulated Chemokine/CCL17 Is a Useful Biomarker for Discriminating Acute Eosinophilic Pneumonia From Other Causes of Acute Lung Injury
Chest, June 1, 2007; 131(6): 1726 - 1734.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Tasaka, N. Hasegawa, S. Kobayashi, W. Yamada, T. Nishimura, T. Takeuchi, and A. Ishizaka
Serum Indicators for the Diagnosis of Pneumocystis Pneumonia
Chest, April 1, 2007; 131(4): 1173 - 1180.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Sasabayashi, Y. Yamazaki, K. Tsushima, O. Hatayama, and T. Okabe
Usefulness of Bronchoscopic Microsampling To Detect the Pathogenic Bacteria of Respiratory Infection
Chest, February 1, 2007; 131(2): 474 - 479.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Kotani, Y. Kotake, H. Morisaki, J. Takeda, H. Shimizu, T. Ueda, and A. Ishizaka
Activation of a Neutrophil-Derived Inflammatory Response in the Airways During Cardiopulmonary Bypass
Anesth. Analg., December 1, 2006; 103(6): 1394 - 1399.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A R L Medford and A B Millar
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
Thorax, July 1, 2006; 61(7): 621 - 626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Parsons
Bridging the chasm between bench and bedside: translational research in acute lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1086 - L1087.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.